Publication:
Adjuvant chemotherapy and survival after pelvic exenteration for gynecologic cancers in the COREPEX study

Simple item page
dc.contributor.coauthorBizzarri, N.
dc.contributor.coauthorNovák, Z.
dc.contributor.coauthorRicotta, G.
dc.contributor.coauthorCãpîlna, M. E.
dc.contributor.coauthorGiannarelli, D.
dc.contributor.coauthorDomingo, S.
dc.contributor.coauthorChiantera, V.
dc.contributor.coauthorAkıllı, H.
dc.contributor.coauthorCibula, D.
dc.contributor.coauthorZach, D.
dc.contributor.coauthorMiranda, A.
dc.contributor.coauthorKorompelis, P.
dc.contributor.coauthorChacon, E.
dc.contributor.coauthorZapardiel, I.
dc.contributor.coauthorLampe, B.
dc.contributor.coauthorSvintsitskyi, V.
dc.contributor.coauthorMatylevich, O.
dc.contributor.coauthorvan Ramshorst, G. H.
dc.contributor.coauthorDemirkıran, F.
dc.contributor.coauthorLengyel, T.
dc.contributor.coauthorVizzielli, G.
dc.contributor.coauthorLoverro, M.
dc.contributor.coauthorFanfani, F.
dc.contributor.coauthorMarchetti, C.
dc.contributor.coauthorFerron, G.
dc.contributor.coauthorMartinez, A.
dc.contributor.coauthorGauroy, E.
dc.contributor.coauthorLadanyi, E.
dc.contributor.coauthorKiss, L. S.
dc.contributor.coauthorLago, V.
dc.contributor.coauthorMontesinos-Albert, M.
dc.contributor.coauthorDi Donna, M. C.
dc.contributor.coauthorCucinella, G.
dc.contributor.coauthorSlama, J.
dc.contributor.coauthorRosta, V.
dc.contributor.coauthorMuallem, M. Z.
dc.contributor.coauthorKucukmetin, A.
dc.contributor.coauthorFagotti, A.
dc.contributor.coauthorSalehi, S.
dc.contributor.coauthorQuerleu, D.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorTaşkıran, Çağatay
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-07-19T19:48:18Z
dc.date.issued2026
dc.description.abstractThis comparative effectiveness research study investigates whether adjuvant chemotherapy is associated with survival in patients with gynecologic cancer undergoing pelvic exenteration with pelvic lymph node metastasis.
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile96
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile96.6
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1001/jamanetworkopen.2026.20335
dc.identifier.embargoN/A
dc.identifier.issn2574-3805
dc.identifier.issue6
dc.identifier.pubmed42360748
dc.identifier.scopus2-s2.0-105043718650
dc.identifier.urihttp://doi.org/10.1001/jamanetworkopen.2026.20335
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33531
dc.identifier.volume9
dc.identifier.wos001805440400003
dc.keywordsPelvic exenteration
dc.keywordsAdjuvant chemotherapy
dc.keywordsChemotherapy
dc.keywordsGynecologic cancer
dc.keywordsLymph node
dc.keywordsGynecologic oncology
dc.keywordsAdjuvant
dc.keywordsPelvic endometriosis
dc.languageeng
dc.publisherAmerican Medical Association (AMA)
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJama Network Open
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectMedicine
dc.subjectObstetrics and gynecology
dc.subjectOncology
dc.subjectReproductive medicine
dc.titleAdjuvant chemotherapy and survival after pelvic exenteration for gynecologic cancers in the COREPEX study
dc.typeLetter
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext